INBS Earnings — Intelligent Bio Solutions Inc. Common Stock Post-ER Performance | BigEarnings
INBS — Intelligent Bio Solutions Inc. Common Stock
XNAS · Healthcare · Medical Devices
Price$2.51
Market Cap$7.6M
P/E—
52W Range$1.52 – $24.90
Next Earnings2026-11-11
About Intelligent Bio Solutions Inc. Common Stock
Intelligent Bio Solutions Inc is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its current active product is the Intelligent Fingerprinting Platform, consisting of a proprietary portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader. Its flagship product, the Intelligent Fingerprinting Drug Screening System, is a two-part system of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse, including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Company operates in APAC, the UK, the Americas, and the rest of the world, with maximum revenue from the United Kingdom.
🤖 AI Earnings Analysis
Completion of the multi-site method comparison study is a key de-risking step for its **FDA 510(k)** codeine submission, a meaningful catalyst for this tiny med-tech name. But the quarter was weak overall: revenue was only **$1M** and operating loss widened to **$3M**.
